3.45 USD
▲-0.07+0.88%
盘后 3.26 -4.68%
2026-08-03
市值
$18.57M
市盈率
—
EPS
-2.16
股息率
—
52 周区间
1.83 – 7.64
成交量
5.71K
Beta
0.57
目标价
—
52W 低 1.8352W 高 7.64
价格走势
公司简介
NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep dis...